Cited by 39Ubiquitin and proteasome pathwaysCancer-related Molecular PathwaysMechanisms of cancer metastasis

KLHL39 suppresses colon cancer metastasis by blocking KLHL20-mediated PML and DAPK ubiquitination

Chen, H Y, Hu, J Y, Chen, T H, Lin, Y C, Liu, X, Lin, M Y, Lang, Y D, Yen, Y +1 more·2015·Oncogene

Abstract

Cullin 3 (Cul3)-family ubiquitin ligases use the BTB-domain-containing proteins for the recruitment of substrates, but the regulation of this family of ubiquitin ligases has not been completely understood. KLHL20 is a BTB-family protein and targets tumor suppressor promyelocytic leukemia protein (PML) and death-associated protein kinase (DAPK) to its kelch-repeat domain for ubiquitination and degradation. Here, we show that another BTB-kelch protein KLHL39 is recruited to the substrate-binding domain of KLHL20 but is not a substrate of Cul3-KLHL20 complex. Interestingly, KLHL39 does not bind Cul3 because of the absence of certain conserved residues in the BTB domain. Instead, KLHL39 blocks KLHL20-mediated ubiquitination of PML and DAPK by disrupting the binding of these substrates to KLHL20 as well as the binding of KLHL20 to Cul3. Through the two mechanisms, KLHL39 increases the stability of PML and DAPK. In human colon cancers, downregulations of KLHL39, PML and DAPK are associated with metastatic progression. Furthermore, preclinical data indicate that KLHL39 promotes colon cancer migration, invasion and survival in vitro and metastasis in vivo through a PML- and DAPK-dependent mechanism. Our study identifies KLHL39 as a negative regulator of Cul3-KLHL20 ubiquitin ligase and reveals a role of KLHL39-mediated PML and DAPK stabilization in colon cancer metastasis.

Integrity signals

Registry

Crossref · 10.1038/onc.2014.435

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • KLHL39 appears to function as an antagonist that blocks ubiquitylation and degradation of PML and DAPK1 by KLHL20.

    “the BTB-Kelch family member KLHL39 appears to function as an antagonist that blocks the ubiquitylation and degradation of PML and DAPK1 by KLHL20 (ref. 95 ).”

    From Targeted protein degradation: expanding the toolbox (2019) · cites this paper as [95]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chen, H. Y., Hu, J. Y., Chen, T. H., Lin, Y. C., Liu, X., Lin, M. Y., Lang, Y. D., Yen, Y., & Chen, R. H.
Affiliations
  • Institute of Biological Chemistry, Academia Sinica (TW)
  • National Taiwan University (TW)
  • Taipei Medical University (TW)
  • Institute of Biomedical Sciences, Academia Sinica (TW)
Corresponding author
Chen, R H
Venue
Oncogene
Published
2015-01-26
Volume
34
Issue
40
Pages
5141-5151
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2057911349
Cited by
39
References
40
Citations by year
2026: 4 · 2025: 2 · 2024: 6 · 2023: 3 · 2022: 5 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 1
FWCI
1.88
Type
journal article
Language
en
Open access
closed
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
Funders
Academia Sinica
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords
colon cancer metastasis, PML, DAPK, ubiquitination, protein stability, tumor suppressor proteins, cell migration and invasion, metastatic progression
MeSH terms
Promyelocytic Leukemia Protein, Animals, Carrier Proteins, Colonic Neoplasms, Female, Humans, Immunohistochemistry, Mice, Nude, Neoplasm Invasiveness, Neoplasm Metastasis, Nuclear Proteins, Transcription Factors, Transfection, RNA-Binding Proteins, Tumor Suppressor Proteins, RNA Interference, Cell Line, Tumor, Tissue Array Analysis, Immunoprecipitation, Adaptor Proteins, Signal Transducing, Mice, Ubiquitination, Death-Associated Protein Kinases, Heterografts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review